← Back to deals
Modern at-home allergy immunotherapy that replaces years of in-office shots
acquireOnline / Digital
Asking Price
$2,899,611
Revenue
$2,200,000
Cash Flow
$126,400
UNKNOWN
Multiple
22.94x
Details
Location: Inc., CA
URL: View listing
First seen: 9/9/2026
Last seen: 9/9/2026
This is a national telehealth platform focused on physician-guided, at-home allergy immunotherapy via a subscription model, helping patients access long-term, disease-modifying treatment without frequent in-office visits, while operating a fully compliant infrastructure licensed across all 50 states with integrated clinical, pharmacy, and technology workflows that support durable recurring revenue through multi-year treatment durations, strong retention, and efficient customer acquisition, al...
Score Breakdown
No scores computed yet.